blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3998095

EP3998095 - DEVICE FOR SUSTAINED DELIVERY OF A THERAPEUTIC FLUID [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  29.12.2023
Database last updated on 17.08.2024
FormerGrant of patent is intended
Status updated on  30.08.2023
FormerExamination is in progress
Status updated on  15.04.2022
Most recent event   Tooltip05.07.2024Lapse of the patent in a contracting statepublished on 07.08.2024  [2024/32]
Applicant(s)For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MT  NL  PL  PT  RO  SE  SI  SK  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
For:DE 
Roche Diabetes Care GmbH
Sandhofer Straße 116
68305 Mannheim / DE
[2022/19]
Inventor(s)01 / IDDAN, Gavriel J.
34602 Haifa / IL
02 / NETA, Avraham
20103 Gilon / IL
03 / YODFAT, Ofer
71725 Modi'in / IL
 [2022/19]
Representative(s)Pfaffmann, Lucas
Roche Diabetes Care GmbH
Patentabteilung
Sandhofer Str. 116
68305 Mannheim / DE
[2022/19]
Application number, filing date21211809.520.12.2007
[2022/20]
Priority number, dateUS20060876679P22.12.2006         Original published format: US 876679 P
[2022/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3998095
Date:18.05.2022
Language:EN
[2022/20]
Type: B1 Patent specification 
No.:EP3998095
Date:31.01.2024
Language:EN
[2024/05]
Search report(s)(Supplementary) European search report - dispatched on:EP04.04.2022
ClassificationIPC:A61M5/142, A61M5/158, A61M39/04
[2022/19]
CPC:
A61M5/14248 (EP,US); A61M39/04 (US); A61M5/14224 (US);
A61M5/14232 (EP,US); A61M5/1424 (US); A61M5/158 (EP,US);
A61M5/16831 (US); A61M5/172 (US); A61M2005/14252 (US);
A61M2005/14268 (EP,US); A61M2005/1581 (EP,US); A61M2005/1585 (EP,US);
A61M2005/16863 (US); A61M2205/52 (US); A61M2209/01 (US);
A61M2209/045 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2022/52]
Former [2022/19]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VORRICHTUNG ZUR VERZÖGERTEN ABGABE EINES THERAPEUTISCHEN FLUIDS[2022/19]
English:DEVICE FOR SUSTAINED DELIVERY OF A THERAPEUTIC FLUID[2022/19]
French:DISPOSITIF D'ADMINISTRATION SOUTENUE D'UN FLUIDE THÉRAPEUTIQUE[2022/19]
Examination procedure01.12.2021Examination requested  [2022/20]
04.04.2022Date on which the examining division has become responsible
14.04.2022Despatch of a communication from the examining division (Time limit: M04)
23.08.2022Reply to a communication from the examining division
06.10.2022Observations by third parties
16.01.2023Despatch of a communication from the examining division (Time limit: M04)
23.05.2023Reply to a communication from the examining division
05.07.2023Observations by third parties
24.07.2023Despatch of a communication from the examining division (Time limit: M04)
02.08.2023Reply to a communication from the examining division
31.08.2023Communication of intention to grant the patent
10.11.2023Fee for grant paid
10.11.2023Fee for publishing/printing paid
10.11.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07849604.9  / EP2125077
EP18163685.3  / EP3400979
EP19206870.8  / EP3632488
Divisional application(s)EP24153664.8  / EP4385551
Fees paidRenewal fee
01.04.2022Renewal fee patent year 03
01.04.2022Renewal fee patent year 04
01.04.2022Renewal fee patent year 05
01.04.2022Renewal fee patent year 06
01.04.2022Renewal fee patent year 07
01.04.2022Renewal fee patent year 08
01.04.2022Renewal fee patent year 09
01.04.2022Renewal fee patent year 10
01.04.2022Renewal fee patent year 11
01.04.2022Renewal fee patent year 12
01.04.2022Renewal fee patent year 13
01.04.2022Renewal fee patent year 14
01.04.2022Renewal fee patent year 15
09.12.2022Renewal fee patent year 16
19.12.2023Renewal fee patent year 17
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipIS31.05.2024
[2024/32]
Documents cited:Search[XA]WO2006108809  (NOVO NORDISK AS [DK], et al)
by applicantUS2631847
 US3771694
 US4498843
 US4544369
 US4657486
 US5957895
 US6485461
 US6589229
 US6699218
 US6723072
 US6740059
 US19600608386
 US20060397115
otherUS5960797
 WO2004071556
 WO2006015600
 WO2006097111
 WO2006108809
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.